CStone Pharmaceuticals Financial Overview
CStone Pharmaceuticals's market cap is currently HK$8.75B. The company's EPS TTM is HK$-0.2293234839; its P/E ratio is -18.74; CStone Pharmaceuticals is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is HK$-0.11. See an overview of income statement, balance sheet, and cash flow financials.
